Samil Pharmaceutical Co.,Ltd (KRX:000520)

KRX:000520 Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,137	906.14	1,903	3,992	15,997
Short-Term Investments	-	-	-	11,269	1,200
Cash & Short-Term Investments	5,137	906.14	1,903	15,261	17,197
Cash Growth	466.91%	-52.40%	-87.53%	-11.26%	-42.20%
Accounts Receivable	35,025	35,813	34,181	31,012	30,137
Other Receivables	754.71	86.62	123.85	120.23	57.85
Receivables	35,779	35,900	34,304	31,133	30,195
Inventory	34,770	32,511	24,742	24,177	24,084
Prepaid Expenses	12,189	11,159	-	-	767.79
Other Current Assets	3,469	638.27	13,832	6,140	279.56
Total Current Assets	91,346	81,115	74,781	76,711	72,523
Property, Plant & Equipment	252,893	242,198	233,946	103,394	64,808
Long-Term Investments	719.88	797.39	782.42	838.64	1,066
Other Intangible Assets	4,708	1,917	3,136	1,295	1,726
Long-Term Accounts Receivable	1,033	0	0	0	0
Long-Term Deferred Tax Assets	-	-	-	-	1,927
Long-Term Deferred Charges	804.2	902.04	-	-	-
Other Long-Term Assets	43,567	43,750	44,054	44,167	49,610
Total Assets	395,071	370,680	356,700	226,405	191,661
Accounts Payable	19,159	21,004	13,660	8,541	10,826
Accrued Expenses	4,054	3,282	4,013	11,153	3,842
Short-Term Debt	54,184	74,868	80,562	75,733	57,356
Current Portion of Long-Term Debt	9,164	49,830	4,940	16,560	16,416
Current Portion of Leases	685.6	387.37	452.59	308.27	323.43
Current Income Taxes Payable	1,646	2,417	1,949	-	1,686
Current Unearned Revenue	123.72	112.34	179.99	171.28	171.02
Other Current Liabilities	17,645	16,774	26,836	9,208	8,064
Total Current Liabilities	106,660	168,675	132,592	121,674	98,684
Long-Term Debt	84,390	49,568	71,918	31,911	20,000
Long-Term Leases	1,659	1,225	1,387	1,003	306.55
Long-Term Unearned Revenue	6.27	36.38	66.15	222.65	385.44
Long-Term Deferred Tax Liabilities	7,493	9,752	13,172	-	-
Other Long-Term Liabilities	1,748	2,286	5,120	4,202	4,139
Total Liabilities	218,947	242,853	230,881	160,658	128,110
Common Stock	10,846	7,613	6,857	6,769	6,695
Additional Paid-In Capital	86,145	44,008	40,481	35,248	26,752
Retained Earnings	19,937	28,019	26,605	27,741	35,034
Treasury Stock	-2,517	-4,161	-4,142	-5,431	-3,765
Comprehensive Income & Other	61,713	52,349	56,019	1,420	-1,164
Shareholders' Equity	176,124	127,827	125,820	65,746	63,551
Total Liabilities & Equity	395,071	370,680	356,700	226,405	191,661
Total Debt	150,081	175,879	159,258	125,515	94,403
Net Cash (Debt)	-144,944	-174,973	-157,355	-110,254	-77,205
Net Cash Per Share	-8059.88	-12095.82	-11286.13	-7972.68	-5741.73
Filing Date Shares Outstanding	19.6	14.46	14.25	13.77	13.77
Total Common Shares Outstanding	19.6	14.46	14.25	13.77	13.77
Working Capital	-15,314	-87,560	-57,811	-44,964	-26,160
Book Value Per Share	8986.11	8838.31	8830.45	4776.06	4616.27
Tangible Book Value	171,416	125,911	122,683	64,451	61,825
Tangible Book Value Per Share	8745.93	8705.79	8610.32	4681.97	4490.90
Land	64,487	64,487	67,149	2,501	2,578
Buildings	149,900	47,136	47,154	46,000	43,986
Machinery	87,698	44,846	43,178	44,758	42,591
Construction In Progress	41.7	132,199	120,009	55,341	22,792

Source: S&P Global Market Intelligence. Standard template. Financial Sources.